These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 20707674

  • 21. Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy.
    Teckman JH.
    COPD; 2013 Mar; 10 Suppl 1():35-43. PubMed ID: 23527737
    [Abstract] [Full Text] [Related]

  • 22. Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations.
    Greene CM, Miller SD, Carroll T, McLean C, O'Mahony M, Lawless MW, O'Neill SJ, Taggart CC, McElvaney NG.
    J Inherit Metab Dis; 2008 Feb; 31(1):21-34. PubMed ID: 18193338
    [Abstract] [Full Text] [Related]

  • 23. Alpha-1-antitrypsin deficiency: accumulation or degradation of mutant variants within the hepatic endoplasmic reticulum.
    Sifers RN, Finegold MJ, Woo SL.
    Am J Respir Cell Mol Biol; 1989 Nov; 1(5):341-5. PubMed ID: 2700304
    [Abstract] [Full Text] [Related]

  • 24. Autophagy-enhancing drug carbamazepine diminishes hepatocellular death in fibrinogen storage disease.
    Puls F, Goldschmidt I, Bantel H, Agne C, Bröcker V, Dämmrich M, Lehmann U, Berrang J, Pfister ED, Kreipe HH, Baumann U.
    J Hepatol; 2013 Sep; 59(3):626-30. PubMed ID: 23707368
    [Abstract] [Full Text] [Related]

  • 25. Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology.
    Lomas DA, Parfrey H.
    Thorax; 2004 Jun; 59(6):529-35. PubMed ID: 15170041
    [Abstract] [Full Text] [Related]

  • 26. Liver disease in alpha 1-antitrypsin deficiency: a review.
    Fairbanks KD, Tavill AS.
    Am J Gastroenterol; 2008 Aug; 103(8):2136-41; quiz 2142. PubMed ID: 18796107
    [Abstract] [Full Text] [Related]

  • 27. Fasting in alpha1-antitrypsin deficient liver: constitutive [correction of consultative] activation of autophagy.
    Teckman JH, An JK, Loethen S, Perlmutter DH.
    Am J Physiol Gastrointest Liver Physiol; 2002 Nov; 283(5):G1156-65. PubMed ID: 12381530
    [Abstract] [Full Text] [Related]

  • 28. The mechanism of Z alpha 1-antitrypsin accumulation in the liver.
    Lomas DA, Evans DL, Finch JT, Carrell RW.
    Nature; 1992 Jun 18; 357(6379):605-7. PubMed ID: 1608473
    [Abstract] [Full Text] [Related]

  • 29. Lack of effect of oral 4-phenylbutyrate on serum alpha-1-antitrypsin in patients with alpha-1-antitrypsin deficiency: a preliminary study.
    Teckman JH.
    J Pediatr Gastroenterol Nutr; 2004 Jul 18; 39(1):34-7. PubMed ID: 15187777
    [Abstract] [Full Text] [Related]

  • 30. Population genetic screening for alpha1-antitrypsin deficiency in a high-prevalence area.
    Corda L, Medicina D, La Piana GE, Bertella E, Moretti G, Bianchi L, Pinelli V, Savoldi G, Baiardi P, Facchetti F, Gatta N, Annesi-Maesano I, Balbi B.
    Respiration; 2011 Jul 18; 82(5):418-25. PubMed ID: 21474916
    [Abstract] [Full Text] [Related]

  • 31. Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis.
    Mencin A, Seki E, Osawa Y, Kodama Y, De Minicis S, Knowles M, Brenner DA.
    Hepatology; 2007 Nov 18; 46(5):1443-52. PubMed ID: 17668872
    [Abstract] [Full Text] [Related]

  • 32. [Autophagic degradation of unfolding proteins].
    Kimura S, Kamimoto T, Yoshimori T.
    Tanpakushitsu Kakusan Koso; 2006 Aug 18; 51(10 Suppl):1494-8. PubMed ID: 16922426
    [No Abstract] [Full Text] [Related]

  • 33. [From gene disease; alpha1-antitrypsine deficiency].
    Hiemstra PS, Stolk J.
    Ned Tijdschr Geneeskd; 2003 Apr 19; 147(16):758-60. PubMed ID: 12731467
    [Abstract] [Full Text] [Related]

  • 34. Capitalizing on the autophagic response for treatment of liver disease caused by alpha-1-antitrypsin deficiency and other genetic diseases.
    Chu AS, Perlmutter DH, Wang Y.
    Biomed Res Int; 2014 Apr 19; 2014():459823. PubMed ID: 25025052
    [Abstract] [Full Text] [Related]

  • 35. Induced pluripotent stem cells model personalized variations in liver disease resulting from α1-antitrypsin deficiency.
    Tafaleng EN, Chakraborty S, Han B, Hale P, Wu W, Soto-Gutierrez A, Feghali-Bostwick CA, Wilson AA, Kotton DN, Nagaya M, Strom SC, Roy-Chowdhury J, Stolz DB, Perlmutter DH, Fox IJ.
    Hepatology; 2015 Jul 19; 62(1):147-57. PubMed ID: 25690322
    [Abstract] [Full Text] [Related]

  • 36. Alpha-1-antitrypsin deficiency.
    Perlmutter DH.
    Semin Liver Dis; 1998 Jul 19; 18(3):217-25. PubMed ID: 9773422
    [Abstract] [Full Text] [Related]

  • 37. Alpha-1-antitrypsin deficiency: diagnosis and treatment.
    Perlmutter DH.
    Clin Liver Dis; 2004 Nov 19; 8(4):839-59, viii-ix. PubMed ID: 15464658
    [Abstract] [Full Text] [Related]

  • 38. NFκB mitigates the pathological effects of misfolded α1-antitrypsin by activating autophagy and an integrated program of proteostasis mechanisms.
    Mukherjee A, Hidvegi T, Araya P, Ewing M, Stolz DB, Perlmutter DH.
    Cell Death Differ; 2019 Mar 19; 26(3):455-469. PubMed ID: 29795336
    [Abstract] [Full Text] [Related]

  • 39. Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency.
    Perlmutter DH.
    Pediatr Res; 2006 Aug 19; 60(2):233-8. PubMed ID: 16864711
    [Abstract] [Full Text] [Related]

  • 40. Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiency.
    Li J, Pak SC, O'Reilly LP, Benson JA, Wang Y, Hidvegi T, Hale P, Dippold C, Ewing M, Silverman GA, Perlmutter DH.
    PLoS One; 2014 Aug 19; 9(1):e87260. PubMed ID: 24498058
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.